Table 5 Physical Functioning and PTSD Treatment Retention

A. Limitations in Physical Functioning

Medications,aOR (95 % CI)

Psychotherapyb,OR (95 % CI)

Model 1

Model 2

Model 1

Model 2

PTSD symptoms (PCL-M)

1.04

(1.03, 1.04)

1.04

(1.03, 1.04)

1.03

(1.02, 1.03)

1.03

(1.02, 1.03)

Physical functioning^c:

Limited a little

0.94

(0.78, 1.13)

0.95

(0.79, 1.15)

0.85

(0.67, 1.08)

0.87

(0.68, 1.10)

Limited a lot

0.96

(0.79, 1.17)

1.01

(0.83, 1.22)

0.69

(0.53, 0.89)

0.73

(0.56, 0.95)

# Chronic physical health conditions^d:

1

—

0.70

(0.58, 0.84)

—

0.51

(0.39, 0.66)

2+

—

0.62

(0.49, 0.78)

—

0.49

(0.35, 0.68)

B. Role Limitations Due to Physical Health

Medications*, OR (95 % CI)

Psychotherapy*, OR (95 % CI)

Model 1

Model 2

Model 1

Model 2

PTSD symptoms (PCL-M)

1.03

(1.03, 1.04)

1.03

(1.03, 1.04)

1.03

(1.02, 1.03)

1.03

(1.02, 1.03)

Role limitations^e:

A little or some of the time

1.16

(0.87, 1.56)

1.17

(0.87, 1.57)

1.26

(0.85, 1.88)

1.28

(0.86, 1.90)

Most or all of the time

1.22

(0.91, 1.64)

1.24

(0.92, 1.67)

1.07

(0.72, 1.61)

1.11

(0.74, 1.66)

# Chronic physical health conditions^d:

1

—

0.70

(0.58, 0.84)

—

0.50

(0.39, 0.66)

2+

—

0.62

(0.49, 0.78)

—

0.48

(0.35, 0.66)